Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,948,998
  • Shares Outstanding, K 29,844
  • Annual Sales, $ 2,546 M
  • Annual Income, $ 3,806 M
  • 60-Month Beta 0.80
  • Price/Sales 6.59
  • Price/Cash Flow 52.87
  • Price/Book 1.70
Trade BIO with:

Options Overview

Details
  • Implied Volatility 36.50%
  • Historical Volatility 33.68%
  • IV Percentile 45%
  • IV Rank 22.56%
  • IV High 67.96% on 03/16/20
  • IV Low 27.34% on 08/18/20
  • Put/Call Vol Ratio 0.21
  • Today's Volume 29
  • Volume Avg (30-Day) 116
  • Put/Call OI Ratio 2.14
  • Today's Open Interest 110
  • Open Int (30-Day) 249

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 2.50
  • Number of Estimates 1
  • High Estimate 2.50
  • Low Estimate 2.50
  • Prior Year 1.91
  • Growth Rate Est. (year over year) +30.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
552.85 +2.72%
on 03/05/21
689.00 -17.57%
on 02/12/21
-48.56 (-7.88%)
since 02/05/21
3-Month
537.12 +5.73%
on 12/09/20
689.00 -17.57%
on 02/12/21
+8.52 (+1.52%)
since 12/04/20
52-Week
309.38 +83.57%
on 03/23/20
689.00 -17.57%
on 02/12/21
+181.24 (+46.87%)
since 03/05/20

Most Recent Stories

More News
Bio-Rad to Participate in Barclays Global Healthcare Conference 2021

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive...

BIO : 567.92 (+1.05%)
Bio-Rad to Participate in Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive...

BIO : 567.92 (+1.05%)
What Makes Bio-Rad Laboratories (BIO) a Strong Momentum Stock: Buy Now?

Does Bio-Rad Laboratories (BIO) have what it takes to be a top stock pick for momentum investors? Let's find out.

BIO : 567.92 (+1.05%)
Bio-Rad (BIO) Q4 Earnings Surpass Estimates, Margins Rise

Bio-Rad's (BIO) fourth-quarter 2020 results reflect strong performance by the Life Science segment, boosted by coronavirus-led increased testing demand.

HOLX : 72.35 (+2.76%)
ABT : 117.25 (+1.07%)
BIO : 567.92 (+1.05%)
IDXX : 499.70 (+2.85%)
Bio-Rad Laboratories (BIO) Q4 Earnings and Revenues Surpass Estimates

Bio-Rad (BIO) delivered earnings and revenue surprises of 29.35% and 15.85%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

BIO : 567.92 (+1.05%)
Bio-Rad: 4Q Earnings Snapshot

HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO.B) on Thursday reported fourth-quarter earnings of $839.1 million.

BIO : 567.92 (+1.05%)
Bio-Rad: 4Q Earnings Snapshot

HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO) on Thursday reported fourth-quarter net income of $839.1 million.

BIO : 567.92 (+1.05%)
Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the fourth quarter ended December 31, 2020....

BIO : 567.92 (+1.05%)
Medical Products' Feb 11 Earnings Roster: DXCM, LH & More

The Medical Product companies' fourth-quarter results are likely to reflect huge adoption of COVID-19 related healthcare-support products and services despite the impact of the ongoing pandemic.

DXCM : 364.09 (+2.19%)
LH : 237.80 (+1.23%)
BIO : 567.92 (+1.05%)
AMWL : 21.34 (-4.52%)
Bio-Rad (BIO) to Report Q4 Earnings: What's in the Cards?

Bio-Rad (BIO) Q4 earnings are expected to have benefited from strong sales, particularly within core PCR products, Droplet Digital PCR and Process Media.

XRAY : 60.00 (+2.20%)
BIO : 567.92 (+1.05%)
RDUS : 21.47 (+3.67%)
OPCH : 18.94 (+2.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials,...

See More

Key Turning Points

3rd Resistance Point 593.86
2nd Resistance Point 582.64
1st Resistance Point 575.28
Last Price 567.92
1st Support Level 556.71
2nd Support Level 545.49
3rd Support Level 538.13

See More

52-Week High 689.00
Last Price 567.92
Fibonacci 61.8% 543.99
Fibonacci 50% 499.19
Fibonacci 38.2% 454.39
52-Week Low 309.38

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar